| D |
2026-08-04 16:40 |
2026-08-01 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Levy Richard S |
Dir |
M - OptEx |
— |
+403 |
22.4K |
+2% |
— |
| D |
2026-06-18 16:21 |
2026-06-17 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
A - Grant |
$0.00 |
+454 |
22.5K |
+2% |
$0 |
| D |
2026-06-02 16:44 |
2026-05-29 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Levy Richard S |
Dir |
M - OptEx |
— |
+2,799 |
22.0K |
+15% |
— |
| MT |
2026-05-22 18:01 |
2026-05-22 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
S - Sale |
$515.44 |
-5,682 |
22.0K |
-21% |
-$2.93M |
| D |
2026-02-24 |
2026-02-23 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
M - OptEx |
$7.36 |
+2,500 |
27.7K |
+10% |
+$18.4K |
| D |
2026-02-04 |
2026-02-01 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Levy Richard S |
Dir |
M - OptEx |
— |
+683 |
19.2K |
+4% |
— |
| D |
2026-01-26 |
2026-01-26 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
M - OptEx |
$16.46 |
+4,000 |
25.2K |
+19% |
+$65.8K |
| DM |
2025-11-14 |
2025-11-13 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
S - Sale+OE |
$520.96 |
-8,500 |
21.2K |
-29% |
-$4.43M |
| DM |
2025-11-14 |
2025-11-13 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
M - OptEx |
$13.78 |
+8,500 |
29.7K |
+40% |
+$117.2K |
| D |
2025-07-03 |
2025-07-01 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Levy Richard S |
Dir |
M - OptEx |
— |
+1,101 |
18.5K |
+6% |
— |
| D |
2025-06-24 |
2025-06-20 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
A - Grant |
$0.00 |
+715 |
21.2K |
+3% |
$0 |
| D |
2025-06-05 |
2025-06-05 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Levy Richard S |
Dir |
M - OptEx |
— |
+3,173 |
17.4K |
+22% |
— |
| A |
2025-05-19 |
2025-05-14 |
TARA |
Protara Therapeutics, Inc. |
Levy Richard S |
Dir |
P - Purchase |
$3.19 |
+20.0K |
51.0K |
+65% |
+$63.8K |
|
2025-05-16 |
2025-05-14 |
TARA |
Protara Therapeutics, Inc. |
Levy Richard S |
Dir |
P - Purchase |
$3.19 |
+20.0K |
51.0K |
+65% |
+$63.8K |
| D |
2025-04-11 |
2025-04-10 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
M - OptEx |
$65.06 |
+9,470 |
20.5K |
+86% |
+$616.1K |
| D |
2024-11-12 |
2024-11-07 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Levy Richard S |
Dir |
M - OptEx |
— |
+1,303 |
14.2K |
+10% |
— |
| DT |
2024-11-08 |
2024-11-07 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
M - OptEx |
$7.36 |
+5,000 |
16.0K |
+45% |
+$36.8K |
| DT |
2024-11-08 |
2024-11-07 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
S - Sale+OE |
$350.00 |
-5,000 |
11.0K |
-31% |
-$1.75M |
| DMT |
2024-11-05 |
2024-11-01 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
S - Sale+OE |
$300.94 |
-5,000 |
11.0K |
-31% |
-$1.50M |
| DT |
2024-11-05 |
2024-11-01 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
M - OptEx |
$7.36 |
+5,000 |
16.0K |
+45% |
+$36.8K |
| D |
2024-06-27 |
2024-06-25 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
A - Grant |
$0.00 |
+714 |
11.0K |
+7% |
$0 |
| D |
2024-06-07 |
2024-06-06 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Levy Richard S |
Dir |
M - OptEx |
— |
+4,373 |
12.9K |
+51% |
— |
| D |
2024-05-07 |
2024-05-03 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Levy Richard S |
Dir |
M - OptEx |
— |
+747 |
8,524 |
+10% |
— |
| DMT |
2024-04-03 |
2024-04-01 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
M - OptEx |
$63.92 |
+11.0K |
21.3K |
+107% |
+$703.2K |
| DMT |
2024-04-03 |
2024-04-01 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
S - Sale+OE |
$257.48 |
-11.0K |
10.3K |
-52% |
-$2.83M |
| D |
2023-11-07 |
2023-11-03 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Levy Richard S |
Dir |
M - OptEx |
— |
+2,777 |
7,777 |
+56% |
— |
| D |
2023-07-03 |
2023-06-29 |
KNSA |
Kiniksa Pharmaceuticals International, plc |
Levy Richard S |
Dir |
M - OptEx |
— |
+5,000 |
5,000 |
New |
— |
|
2023-06-20 |
2023-06-15 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
A - Grant |
$0.00 |
+1,198 |
10.3K |
+13% |
$0 |
| DM |
2023-01-19 |
2023-01-17 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
M - OptEx |
$103.02 |
+22.5K |
21.6K |
New |
+$2.32M |
| DM |
2023-01-19 |
2023-01-17 |
MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
Levy Richard S |
Dir |
S - Sale+OE |
$293.15 |
-22.5K |
31.5K |
-42% |
-$6.59M |